Sökning: "antiplatelet therapy"

Visar resultat 11 - 15 av 24 avhandlingar innehållade orden antiplatelet therapy.

1. 11. Fibrinogen, platelet and factor XIII supplementation in cardiac surgery: In vitro and in vivo studies

   Författare :Caroline Andersson Shams Hakimi; Göteborgs universitet; []
   Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; fibrinogen; platelets; factor XIII; platelet aggregation; clot formation; cardiac surgery;

   Sammanfattning : Background: There is a high risk of bleeding complications in cardiac surgery. Fibrinogen and platelet concentrates are often used to treat perioperative bleeding, but there is little information about its efficacy. LÄS MER

3. 12. Socioeconomic status and myocardial infarction : influence on secondary prevention and prognosis

   Författare :Joel Ohm; Karolinska Institutet; Karolinska Institutet; []
   Nyckelord :;

   Sammanfattning : Background and Aims: In the wealth of research undertaken on myocardial infarctions (MIs), secondary prevention is less well studied. Incidence and death from MI have declined substantially in the past decades due to the identification of cardiovascular (CV) risk factors, methods to assess risk in the general population, development of efficient therapies that modify risk factor levels, and the introduction of revascularization therapies used in the acute phase of a MI. LÄS MER

4. 13. Bleeding complications after acute coronary syndrome with special reference to intracranial hemorrhage

   Författare :Anna Graipe; Thomas Mooe; Fredrik Björklund; Joakim Alfredsson; Umeå universitet; []
   Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Acute myocardial infarction; serious bleeding; intracranial hemorrhage hemorrhagic stroke; Medicine; medicin;

   Sammanfattning : Background: Bleeding complications following acute coronary syndrome (ACS) have attracted considerable attention in recent years. The gradual implementation of new evidence-based treatments in patients with ACS, with a focus on anti-ischemic therapy, has reduced the risk of ischemic events (new myocardial infarction or ischemic stroke) but at the expense of increased bleeding risk. LÄS MER

5. 14. Studies on platelet function and microvesicles in acute coronary syndrome

   Författare :Sam Kafian; Karolinska Institutet; Karolinska Institutet; []
   Nyckelord :;

   Sammanfattning : INTRODUCTION: The cornerstone of treatment of acute coronary syndrome (ACS) is percutaneous coronary intervention (PCI) and dual antiplatelet therapy (DAT) with aspirin and the ADP-receptor inhibitor clopidogrel. However, some ACS patients will suffer from recurrent cardiovascular events, and it has been shown that this may partly be due to an insufficient antiplatelet response to DAT. LÄS MER

7. 15. Platelet Inhibition and Bleeding in Coronary Artery Bypass Surgery

   Författare :Ulrica Alström; Elisabeth Ståhle; Ulf Schött; Uppsala universitet; []
   Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; bleeding; cardiac surgery; platelet inhibition; re-exploration; cost analysis; Anaesthetics and intensive care; Anestesiologi och intensivvård; Thoraxkirurgi; Thorax Surgery; Anaesthesiology and Intensive Care; Anestesiologi och intensivvård;

   Sammanfattning : A substantial number of patients undergoing cardiac surgery are on dual anti-platelet treatment with clopidogrel and aspirin. A disadvantage with this treatment is increased risk of bleeding. Bleeding is a complication of major concern associated with adverse outcome for the patient and increased hospital resource utilization. LÄS MER